Mohsen Malekinejad, MD, DrPH

Title(s)Assistant Professor, Institute for Health Policy Studies
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral Studies2009HIV prevention
    University of California, BerkeleyDrPH2008Public Health
    University of California, DavisMPH2003Public Health
    Tehran Azad University MD1999General Medicine

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Development of a reference web-based database for substance use disorders in Iran
    Iranian National Institute of Medical Research and Development 940043Apr 1, 2016 - Mar 30, 2018
    Role: Co-PI
    Role Description: This project intend to compile data about substance use related indictors in Iran I am the o-PI of this project and will take the lead on the implementation of the project including defining indicators, assist with development of tools and protocol, supervise data synthesis, and contribute to manuscript submission.
    US Center for Disease Control and Prevention # 5U38PS004649Sep 30, 2015 - Sep 30, 2019
    Role: Co-investigator, project lead
    Role Description: This cooperative agreement supports economic analysis for and with CDC for prevention of HIV, hepatitis, TB, and STIs. To conduct analysis of existing data on recruitment strategies for screening of HIV,HCV, HBV, and TB among homeless people and injecting drug users
    Crucial Transitions among Young Opioid Users in Iran
    NIH/NIDA R21DA029473Sep 15, 2010 - Aug 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Global Health
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review. PLoS One. 2019; 14(9):e0223077. PMID: 31568507.
      View in: PubMed
    2. Malekinejad M, Horvath H, Snyder H, Brindis CD. The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders. Health Res Policy Syst. 2018 Aug 16; 16(1):81. PMID: 30115085.
      View in: PubMed
    3. Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review. PLoS One. 2018; 13(7):e0200485. PMID: 30024909.
      View in: PubMed
    4. Marseille E, Mirzazadeh A, Biggs MA, P Miller A, Horvath H, Lightfoot M, Malekinejad M, Kahn JG. Effectiveness of School-Based Teen Pregnancy Prevention Programs in the USA: a Systematic Review and Meta-Analysis. Prev Sci. 2018 05; 19(4):468-489. PMID: 29374797.
      View in: PubMed
    5. Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health. 2018 04 12; 18(1):485. PMID: 29650047.
      View in: PubMed
    6. Noroozi A, Malekinejad M, Rahimi-Movaghar A. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study. J Psychoactive Drugs. 2018 Jul-Aug; 50(3):214-223. PMID: 29377788.
      View in: PubMed
    7. Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review. PLoS One. 2017; 12(8):e0180707. PMID: 28786991.
      View in: PubMed
    8. Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. PMID: 28771484.
      View in: PubMed
    9. Thaker A, Navadeh S, Gonzales H, Malekinejad M. Effectiveness of Policies on Reducing Exposure to Ionizing Radiation From Medical Imaging: A Systematic Review. J Am Coll Radiol. 2015 Dec; 12(12 Pt B):1434-45. PMID: 26499166.
      View in: PubMed
    10. Malekinejad M, Navadeh S, Lotfizadeh A, Rahimi-Movaghar A, Amin-Esmaeili M, Noroozi A. High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012). Int J Infect Dis. 2015 Nov; 40:116-30. PMID: 26460088.
      View in: PubMed
    11. Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence. Int J Drug Policy. 2015 Sep; 26(9):808-19. PMID: 26210009.
      View in: PubMed
    12. Malekinejad M, Mohraz M, Razani N, Akbari G, McFarland W, Khairandish P, Malekafzali H, Gouya MM, Zarghami A, Rutherford GW. High HIV prevalence in a respondent-driven sampling survey of injection drug users in Tehran, Iran. AIDS Behav. 2015 Mar; 19(3):440-9. PMID: 25280446.
      View in: PubMed
    13. Mirzazadeh A, Malekinejad M, Kahn JG. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23. PMID: 25726522.
      View in: PubMed
    14. Rahnama R, Mohraz M, Mirzazadeh A, Rutherford G, McFarland W, Akbari G, Malekinejad M. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. Int J Drug Policy. 2014 Jul; 25(4):717-23. PMID: 24974367.
      View in: PubMed
    15. Malekinejad M, Vazirian M. Transition to injection amongst opioid users in Iran: implications for harm reduction. Int J Drug Policy. 2012 Jul; 23(4):333-7. PMID: 21996166.
      View in: PubMed
    16. Malekinejad M, McFarland W, Vaudrey J, Raymond HF. Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):83-91. PMID: 21435803.
      View in: PubMed
    17. Kral AH, Malekinejad M, Vaudrey J, Martinez AN, Lorvick J, McFarland W, Raymond HF. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010 Sep; 87(5):839-50. PMID: 20582573.
      View in: PubMed
    18. Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008 Jul; 12(4 Suppl):S105-30. PMID: 18561018.
      View in: PubMed
    19. Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008 Jul; 12(4 Suppl):S131-41. PMID: 18535901.
      View in: PubMed
    20. Mojtahedzadeh V, Razani N, Malekinejad M, Vazirian M, Shoaee S, Saberi Zafarghandi MB, Hernandez AL, Mandel JS. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system. AIDS Behav. 2008 Jul; 12(4 Suppl):S7-12. PMID: 18521737.
      View in: PubMed
    21. Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, McFarland W, Rutherford G. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007 Sep; 102(9):1472-82. PMID: 17645427.
      View in: PubMed